Expression of type I interferon receptor and its relation with other prognostic factors in human neuroblastoma

Oncol Rep. 1999 Jan-Feb;6(1):149-53.

Abstract

Expression of type I interferon receptor (IFN-R) has been found in several normal tissues and in malignant neoplasms, mainly those with epithelial differentiation. In order to analyze the immunohistochemical expression of type I IFN-R we studied 79 cases of neuroblastoma. Results of expression of type I IFN-R were statistically correlated with histopathology, stage, bcl-2 and PCNA expression, N-myc amplification and apoptosis. We found expression of type I IFN-R in 54/79 cases showing statistical correlation with bcl-2 expression (P=0.017) and favourable histopathology (P=0.015). The overexpression found in ganglion cells suggests that IFN-R could be involved in the pathway of neuroblastoma differentiation. Moreover, the expression of type I IFN-R in stage 4 cases (12/20), even with N-myc amplification (6/8), opens new possibilities for therapeutic management in advanced cases that do not respond to any chemotherapeutic protocol.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Apoptosis
  • Biomarkers, Tumor / analysis*
  • Cell Differentiation
  • Child
  • Child, Preschool
  • Gene Amplification
  • Genes, myc
  • Humans
  • Immunoenzyme Techniques
  • Infant
  • Membrane Proteins
  • Neoplasm Proteins / analysis*
  • Neoplasm Staging
  • Neuroblastoma / chemistry*
  • Neuroblastoma / genetics
  • Neuroblastoma / mortality
  • Neuroblastoma / pathology
  • Prognosis
  • Proliferating Cell Nuclear Antigen / analysis
  • Proto-Oncogene Proteins c-bcl-2 / analysis
  • Receptor, Interferon alpha-beta
  • Receptors, Interferon / analysis*
  • Spain / epidemiology

Substances

  • Biomarkers, Tumor
  • Membrane Proteins
  • Neoplasm Proteins
  • Proliferating Cell Nuclear Antigen
  • Proto-Oncogene Proteins c-bcl-2
  • Receptors, Interferon
  • Receptor, Interferon alpha-beta